Epigallocatechingallate sensitizes cervical cancer cells to cisplatin via Nrf2/HO-1 and m-Tor signaling pathway

ŞAHİN K., TUZCU M., BAŞAK TÜRKMEN N., orhan c., ÇAĞLAYAN A. B., AĞCA C. A., ...More

5th International Congress on Nutrition and Cancer, 09 September 2012, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Inonu University Affiliated: Yes